Miscellaneous News

RSS

AZoNetwork Launches AZoAI, an Open - Access Platform for the Artificial Intelligence Industry

Leading scientific publisher introduces its 12th subject-specific website, AZoAI.com - the A to Z of Artificial Intelligence. The website educates and informs how the application of artificial intelligence will impact the science, engineering and healthcare sectors and provides industry experts in these fields with the latest news and content from the AI and machine learning industries.

3 Nov 2023

AZoNetwork Launches Azthena, Your Personal Scientific Assistant

Leading scientific publisher introduces an AI assistant trained on 23 years of scientific content.

2 Nov 2023

Study Shows Birds That Have Evolved Greater Complexity are Less Biodiverse

A new study of the evolution of birds shows that as their skeletons become more complex, they also decrease in diversity, with fewer species as they become more specialised in their niches.

26 Sep 2023

Valent BioSciences Announces Construction of New Oregon Facility

Valent BioSciences LLC has announced the construction of a new manufacturing facility in White City, Oregon.

From Valent Biosciences 22 Sep 2023

UK Food-Tech Business Clean Food Group Announces Strategic Collaboration with LATAM Food Technology Specialist, Alianza Team

Pioneering UK-based bio-tech business Clean Food Group is pleased to announce a new investment and strategic collaboration with Alianza Team, the Latin American food production and lipid-based technology expert, a leading company in the world of lipids, nutrition and frozen bakery.

9 Aug 2023

New Nanopore Technology Can Identify Single-Molecule Protein Variations

A group of researchers guided by the University of Oxford has made significant progress in detecting changes in protein structures. The method, which was published in Nature Nanotechnology, uses novel nanopore technology to detect structural variations at the single-molecule level, even deep within long protein chains.

2 Aug 2023

LION™-Formulated repRNA in Next-Gen repRNA Vaccine Platform Appears Promising

The creation of new vaccination technologies continues to be at the forefront of scientific inquiry as the globe fights numerous infectious illnesses. Recent research on illnesses like COVID-19 has shown promise for mRNA-based vaccines and their use of lipid nanoparticles (LNPs) for delivery.

25 Jul 2023

T Cells Play a Dual Role in Wasting During Infection

Even though infections can be presented with several different symptoms, one common symptom is known to be the loss of fat and muscle, a process known as wasting.

25 Jul 2023

Ecological ‘Doom Loops’ Edging Closer

Extreme weather events such as wildfires and droughts will accelerate change in stressed systems leading to quicker tipping points of ecological decline, according to a new study published today in Nature Sustainability.

21 Jun 2023

AIMPLAS Coordinates a New EU Project to Valorize Slaughterhouse Waste and Paper and Pulp Sludge for Agricultural and Personal Care Applications

AIMPLAS, the Plastics Technology Centre, coordinates a new European project to valorize slaughterhouse waste (bellygrass or rumen content) and paper and pulp sludge, to produce cost-efficient polyhydroxyalkanoates (PHAs) for agricultural and personal care applications, by the coprocessing with other organic wastes (OW) such as sludge from the dairy industry and glycerol from the biodiesel industry, as well as recovering nutrients to produce bio-based fertilizers (BBFs).

13 Jun 2023

Hytera Supports ZimParks to Improve Staff Safety and Conserve Wildlife

Hytera Communications, a leading global provider of professional communications technologies and solutions, has partnered with Zimbabwe Parks and Wildlife Management Authority (ZimParks) to improve the safety of rangers working across the parks and reduce wildlife poaching activities.

12 Jun 2023

From Clocks to Cells: Unleashing the Potential of Dual Oscillatory Signaling

Christian Huygens recorded his observations of the synchronization of two pendulum clocks in 1665. It takes precise quantitative control to properly regulate oscillatory dynamics, which are seen in essential biological processes including circadian clocks, segmentation, and transcription factor responses in addition to physical systems.

22 May 2023

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges

From Revvity 9 May 2023

Applying crocodile’s unique pH sensing mechanism to benefit humans

Researchers from La Trobe University have just discovered how crocodiles, despite living in dirty water, prevent deadly fungal infections by employing a unique pH sensing mechanism.

3 Mar 2023

bit.bio partners with Automata to automate a key aspect of its production of iPSC derived human cells

...

From Automata 26 Jan 2023

Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs

...

From Orbit Discovery 5 Jan 2023

The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

...

From The Native Antigen Company 8 Dec 2022

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd. (ASX:EX1), a company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), today announced they had entered into a formal collaboration.

From Sartorius 23 Nov 2022

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced two key appointments to its management team.

From The Native Antigen Company 23 Nov 2022

Astrea Bioseparations introduces Nereus LentiHERO, a fit-for-purpose solution for lentiviral vector purification

Astrea Bioseparations (“Astrea Bio”), a leading provider of novel purification and separation tools supporting the development of next-generation therapeutics, has announced today the commercial launch of its Nereus LentiHERO™ lentiviral vector (LVV) purification technology.

29 Sep 2022